Navigation Links
New Study Evaluates Psychotropic Prescribing For Persons with Intellectual Disabilities, Other Psychiatric Disorders
Date:11/26/2013

PITTSBURGH, Nov. 26, 2013 /PRNewswire/ -- A new report from Community Care Behavioral Health Organization, published in a recent edition of Psychiatric Services in Advance, shows varying psychotropic prescribing patterns in Medicaid recipients (adults and children) with the co-diagnosis of an intellectual disability and a mental health condition, as well as those with a mental health condition diagnosis only.

"We designed this study in response to stakeholder concerns about the use of psychotropic medication among individuals with an intellectual disability," said Gail A. Edelsohn, MD, MSPH, lead author of the study.

To examine the use of psychotropic medication, the study compared:

  • Prescription patterns for four medication classes between the two groups.
  • The pattern of prescribing three or more psychotropic medications concurrently.

The study raises the question about careful use of psychotropics and the importance of recognizing the underlying causes of challenging behaviors, as well as the use of psychosocial interventions in individuals with intellectual disabilities.  Also, the higher rates of prescriptions for mood stabilizers found in the children's co-diagnosis group raises the question about whether medications are being used as anticonvulsants or to treat behavioral health conditions.

The five-year study includes recommendations for behavioral intervention alternatives and careful monitoring of psychotropic effectiveness and side effects.

The full report can be found at http://ps.psychiatryonline.org/Article.aspx?ArticleID=1777608

About Community Care
Community Care Behavioral Health Organization, a nonprofit, tax-exempt recovery-focused behavioral health managed care organization headquartered in Pittsburgh, Pennsylvania, manages mental health and substance use disorder services for approximately 750,000 Medical Assistance recipients in Pennsylvania. Community Care also serves as the behavioral health organization for the Hudson River Region of New York State. Part of UPMC, Community Care was incorporated in 1996 with a mission to improve the health and well-being of the community through the delivery of effective and accessible behavioral health services.


'/>"/>
SOURCE Community Care Behavioral Health Organization
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Isis Pharmaceuticals Initiates Phase 1 Study of ISIS-GSK3 Rx and Earns $3 Million Milestone Payment From GSK
2. Seno Medical Instruments Launches Pivotal Study of New Functional Imaging Platform in Breast Cancer Diagnosis
3. Orexigen Announces Successful Interim Analysis of Contrave Light Study
4. Orexigen Therapeutics to Host Contrave Light Study Interim Analysis Conference Call and Webcast
5. New Study by Imaging the World and Philips Demonstrates the Power of Ultrasound Screenings to Transform Maternal and Newborn Care in Rural Uganda
6. Study Results Reveal Oral Growth Hormone Boosting Supplement May Be Capable of Producing the Same Benefits as Synthetic Growth Hormone Injections
7. Irvine Center for Clinical Research Announces Open Enrollment for New Low Testosterone Study
8. Chicago Man Breathes Again Thanks to Northwestern Medicine Study
9. Phase IIb Study of Vanoxerine Shows Strong Safety and Statistically Significant Efficacy Signals for Treatment of Atrial Fibrillation
10. Zafgen Announces New Weight Loss and Safety Data from Phase 2 Study of Beloranib in Obesity at Obesity Week 2013
11. Epizymes EPZ-5676 DOT1L Inhibitor Demonstrates Encouraging Initial Findings in an Ongoing Phase 1 Dose Escalation Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... 2016 Global Paclitaxel Market 2016 ... 12 companies and the Paclitaxel analysis in this study ... industry and its players. This is the ... details the current state of the industry while providing ... applications and industry chain structure. The Paclitaxel market analysis ...
(Date:5/23/2016)... May 23, 2016 According ... Share, Development, Growth and Demand Forecast to 2022 ... Other), by Application (Drug Discovery and Development, Proteomics, ... (Pharmaceuticals, Life Science and Biotechnology, Academic and Research ... Research, the global mass spectrometry market ...
(Date:5/23/2016)... , May 23, 2016 ... for detection of multiple diseases; ,Technology to be presented ... Yissum Research Development Company of the Hebrew ... into a research agreement with Aurum Ventures MKI, the technology ... development of a new diagnostic approach for early detection ...
Breaking Medicine Technology:
(Date:5/24/2016)... , ... May 24, 2016 , ... How to Write ... Raleigh, NC, http://www.fdanews.com/humanerrordrugdevice , Human error is known to be the major ... human error will ever be totally eliminated, many human performance problems can be prevented. ...
(Date:5/24/2016)... ... May 24, 2016 , ... Loma Linda University Health (LLUH) has officially broken ... Children’s Hospital. Over 3,000 people looked on as the shovels hit the dirt at ... slidehsow. , During the program, Richard H. Hart, MD, DrPH, president, LLUH, recapped ...
(Date:5/24/2016)... ... May 24, 2016 , ... Eggsurance, ... the official relaunch of its community and education hub for women considering fertility ... is to create a safe and welcoming place for women to find cycle ...
(Date:5/24/2016)... ... May 24, 2016 , ... Tuesday, May 24, Women's Excellence in Wellness, powered ... Young Living Essential Oils, taught by Patti Dolan, RYT, a Young Living Gold ... Flow is 6:30pm - 7:15pm followed by a small intro to the Oils that ...
(Date:5/24/2016)... ... May 24, 2016 , ... In light of recent heavy flooding in Houston, ... contaminated well water throughout the Houston area. , Heavy floodwaters have led to destroyed ... to contaminants. Residents may not even be aware of the contamination of their water ...
Breaking Medicine News(10 mins):